Technetium ⁹⁹ᵐTc mebrofenin

Animal reproduction studies have not been conducted with technetium Tc 99m mebrofenin. It is also not known whether technetium Tc 99m mebrofenin can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Technetium Tc 99m mebrofenin should be given to a pregnant woman only if the expected benefits to be gained clearly outweigh the potential hazards.

Technetium Tc 99m is excreted in human milk during lactation. Therefore, formula feedings should be substituted for breast feedings.

No long term animal studies have been performed to evaluate carcinogenic potential or whether technetium Tc 99m mebrofenin may affect fertility in males or females.

Urticaria and rash have been rarely reported with the use of technetium Tc 99m mebrofenin since market introduction. Rare cases of chills and nausea have been reported with related compounds. Infrequently, death has been reported in association with the use of this class of agents.